Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.42 USD
Change Today +0.06 / 1.38%
Volume 159.8K
ALIM On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David R. Holland

Co-Founder and Senior Vice President of Sales & Marketing, Alimera Sciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

50$390,918
As of Fiscal Year 2014

Background*

Mr. David R. Holland, Dave, Co-Founded Alimera Sciences Inc. in 2003 and has been its Senior Vice President of Sales and Marketing since August 2010. Mr. Holland served as Vice President of Marketing at Alimera Sciences Inc. from June 2003 to August 2010. He has eighteen years of experience in healthcare marketing, brand development and strategic marketing, fourteen of those in the ophthalmic market place, he served as Vice President of Marketing, Novartis Ophthalmics, ...

Read Full Background

Corporate Headquarters*

6120 Windward Parkway
Alpharetta, Georgia 30005

United States

Phone: 678-990-5740
Fax: 678-990-5744

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA 1985
Princeton University

Other Affiliations*

Annual Compensation*

Salary$294,203
Bonus$53,160
Total Annual Compensation$347,363

Stock Options*

All Other Compensation$6,343
Exercised Options60,000
Exercised Options Value$366,776
Exercisable Options349,105
Exercisable Options Value$1,063,022
Unexercisable Options203,376
Unexercisable Options Value$698,192
Total Value of Options$2,127,989
Total Number of Options612,481

Total Compensation*

Total Annual Cash Compensation$390,918
Total Short Term Compensation$347,363
Other Long Term Compensation$6,343
Total Calculated Compensation$390,918
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALIM:US $4.42 USD +0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex-Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.2M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Rajat Rai Chief Executive Officer
Akorn, Inc.
$1.1M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
SFr.6.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALIMERA SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.